Digital PCR for Noninvasive Detection of Aneuploidy: Power Analysis Equations for Feasibility

Objective: To determine the feasibility of digital PCR analysis for noninvasive prenatal diagnosis of trisomy 21. Methods: Through power equations, we modeled the number of wells necessary to determine the feasibility of digital PCR as a practical method for trisomy 21 risk assessment. Results: The number of wells needed is a direct correlate of the ability to isolate free fetal DNA. If a 20% fetal DNA enhancement can be achieved, then 2,609 counts would be sufficient to achieve a 99% detection rate for a 1% false-positive rate and potentially feasible with readily available plates. However, if only a 2% increase is seen, then 220,816 counts will be necessary, and over 110,000 would be needed just to achieve 95% for a 5% false-positive rate – both far beyond current commercially available technology. Conclusion: There are several noninvasive prenatal diagnostic methods which may reach commercialization; all have differing potential advantages and disadvantages. Digital PCR is potentially a cheaper methodology for trisomy 21, but it is too early to determine the optimal method.

[1]  K. Nicolaides,et al.  Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.

[2]  S. Nelson,et al.  DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study , 2011, Genetics in Medicine.

[3]  N. Carter,et al.  Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21 , 2011, Nature Medicine.

[4]  C. Cantor,et al.  Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. , 2011, American journal of obstetrics and gynecology.

[5]  Yama W. L. Zheng,et al.  Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study , 2011, BMJ : British Medical Journal.

[6]  Y. Lo Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art , 2009, BJOG : an international journal of obstetrics and gynaecology.

[7]  C. Cantor,et al.  Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma , 2008, Proceedings of the National Academy of Sciences.

[8]  H. C. Fan,et al.  Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood , 2008, Proceedings of the National Academy of Sciences.

[9]  K. Nicolaides,et al.  Detection of circulating fetal cells utilizing automated microscopy: potential for noninvasive prenatal diagnosis of chromosomal aneuploidies , 2008, Prenatal diagnosis.

[10]  Charles R Cantor,et al.  Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection , 2007, Nature Medicine.

[11]  K. Klinger,et al.  Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data , 2002, Prenatal diagnosis.

[12]  I. Sargent,et al.  Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.